For following the competition: what moved in each program, several studies read as one move.
- SCTB41
- Anti-CD38 Monoclonal Antibody SCTC21C
- SCTB35
- + 10 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Sinocelltech Group to watchlistEvery Monday by email · turn it off any timePro · free during the beta